Association of Clinical Research Professionals (ACRP) Certified Professional Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ACRP Certified Professional Exam with our comprehensive quiz. Elevate your clinical research skills with targeted flashcards and multiple-choice questions. Enhance your readiness with detailed explanations and insights for improved performance!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which of the following can help avoid bias in clinical trials?

  1. Using a larger sample size

  2. Blinded assessment of outcomes

  3. Randomization of treatment groups

  4. All of the above

The correct answer is: All of the above

All of the options presented play a significant role in minimizing bias in clinical trials. Using a larger sample size can enhance the reliability of the results, making it easier to detect true effects and reducing the impact of random variability. While this does not directly eliminate bias, it contributes to the overall robustness of the findings, leading to more generalizable conclusions. Blinded assessment of outcomes is crucial for preventing bias, particularly in how outcomes are measured and interpreted. When those assessing outcomes are unaware of which participants received which treatment, it minimizes the risk of consciously or unconsciously influencing results based on knowledge of treatment assignments. Randomization of treatment groups is a foundational aspect of clinical trial design. This method randomly assigns participants to different treatment groups, which helps to ensure that these groups are comparable at baseline. As a result, any differences in outcomes can be more confidently attributed to the treatment itself rather than to pre-existing differences among participants. Each of these strategies addresses different types of bias—such as selection bias, measurement bias, and confounding—making their combined implementation vital for the integrity of clinical research. Thus, choosing all of the mentioned options supports a comprehensive approach to reducing bias in clinical trials.